Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task

Journal of Psychopharmacology

Volumn 27, Issue 2, 2013, Pages 213-221

  Humpston, Clara S ^a   Wood, Christian M ^a   Robinson, Emma S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

5 choice serial reaction time task; ADHD; attention; dopamine; impulsivity; monoamine reuptake; Noradrenaline; rat; serotonin

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; CITALOPRAM; FLUOXETINE; IDAZOXAN; NORADRENALIN; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; VENLAFAXINE;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; CONTROLLED STUDY; DRUG DOSE COMPARISON; IMPULSE CONTROL DISORDER; LATENT PERIOD; MALE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; RAT; RESPONSE TIME; TASK PERFORMANCE;

ACETAMIDES; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BUPROPION; CHOICE BEHAVIOR; CYCLOBUTANES; CYCLOHEXANOLS; FLUOXETINE; HYPNOTICS AND SEDATIVES; IDAZOXAN; IMPULSIVE BEHAVIOR; MALE; NOREPINEPHRINE; PAROXETINE; RATS; REACTION TIME; SEROTONIN UPTAKE INHIBITORS;

EID: 84872870834     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112466182     Document Type: Article

References (80)

1. Acheson A, de Wit H. Bupropion improves attention but does not affect impulsive behaviour in healthy young adults. Exp Clin Psychopharmacol. 2008 ; 16: 113-123
2. Arnsten AF. Stimulants: Therapeutic actions in ADHD. Neuropsychopharmacology. 2006 ; 31: 2376-2383
3. Arnsten AF, Dudley AG. Methylphenidate improves prefrontal cortical cognitive function through alpha2-adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Func. 2005 ; 1: 2
4. Baarendse PJ, Vanderschuren LJ. Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. Psychopharmacology (Berl). 2012 ; 219: 313-326
5. Bari A, Dalley JW, Robbins TW. The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc. 2008 ; 3: 759-767
6. Bari A, Eagle DM, Mar AC, et al. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology (Berl). 2009 ; 205: 273-283
7. Béïque JC, Lavoie N, de Montigny C, et al. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur J Pharmacol. 1998 ; 349: 129-132
8. Bel N, Artigas F. Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats. Neuropsychopharmacology. 1999 ; 21: 745-54
9. Bellino S, Paradiso E, Bozzatello P, et al. Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study. J Psychopharmacol. 2010 ; 24: 333-339
10. Bengtsson HJ, Kele J, Johansson J, et al. Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo. Naunyn Schmiedebergs Arch Pharmacol. 2000 ; 362: 406-412
11. Berridge CW, Devilbiss DM, Andrzejewski ME, et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry. 2006 ; 60: 1111-1120
12. Beyer CE, Boikess S, Luo B, et al. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. J Psychopharmacol. 2002 ; 16: 297-304
13. Blondeau C, Dellu-Hagedorn F. Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry. 2006 ; 61: 1340-1350
14. Braquehais MD, Ramos-Quiroga JA, Sher L. Impulsivity: current and future trends in pharmacological treatment. Exp Rev Neurother. 2010 ; 10: 1367-1369
15. Bymaster FP, Zhang W, Carter PA, et al. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl). 2002 ; 160: 353-361
16. Carli M, Samanin R. Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task. Psychopharmacology (Berl). 1992 ; 106: 228-234
17. Carroll FI, Blough BE, Abraham P, et al. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. J Med Chem. 2009 ; 52: 6768-6781
18. Chamberlain SR, Sahakian BJ. The neuropsychiatry of impulsivity. Curr Opin Psychiatry. 2007 ; 20: 255-261
19. Chamberlain SR, Muller U, Blackwell AD, et al. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science. 2006 ; 311: 861-863
20. Dalley JW, Cardinal RN, Robbins TW. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev. 2004 ; 28: 771-784
21. Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron. 2011 ; 69: 680-694
22. Dalley JW, Mar AC, Economidou D, et al. Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav. 2008 ; 90: 250-260
23. Dawson LA, Nguyen HQ, Geiger A. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. Neuropharmacology. 1999 ; 38: 1153-1163
24. Devoto P, Flore G, Pani L, et al. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry. 2001 ; 6: 657-664
25. Eagle DM, Baunez C. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev. 2010 ; 34: 50-72
26. Evenden JL. Varieties of impulsivity. Psychopharmacology (Berl). 1999a ; 146: 348-361
27. Evenden JL. Impulsivity: a discussion of clinical and experimental findings. J Psychopharmacol. 1999b ; 13: 180-192
28. Fernando AB, Economidou D, Theobald DE, et al. Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacology (Berl). 2012 ; 219: 341-352
29. Floresco SB, Jentsch JD. Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology. 2011 ; 36: 227-250
30. Fone KC, Nutt DJ. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol. 2005 ; 5: 87-93
31. Gilmor ML, Owens MJ, Nemeroff CB. Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine. Am J Psychiatry. 2002 ; 159: 1702-1710
32. Gundlah C, Martin KF, Heal DJ, et al. In vivo criteria to differentiate monoamine uptake inhibitors from releasing drugs: Sibutramine is a reuptake inhibitor. J Pharmacol Exp Ther. 1997 ; 283: 581-591
33. Gvion Y, Apter A. Aggression, impulsivity, and suicide behaviour: a review of the literature. Arch Suicide Res. 2011 ; 15: 93-112
34. Hajos-Korcsok E, McTavish SFB, Sharp T. Effect of a selective 5- hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine. Eur J Pharmacol. 2000 ; 407: 101-107
35. Harrison AA, Everitt BJ, Robbins TW. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl). 1997 ; 133: 329-342
36. Heal DJ, Aspley S, Prow MR, et al. Sibutramine: a novel anti- obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int J Obes Relat Metab Disord. 1998 ; 22: S18 - S28
37. Jäkälä P, Sirviö J, Jolkkonen J, et al. The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. Behav Brain Res. 1992 ; 51: 29-40
38. Javdani S, Sadeh N, Verona E. Suicidality as a function of impulsivity, callous-unemotional traits, and depressive symptoms in youth. J Abnorm Psychol. 2011 ; 120: 400-413
39. Jordan S, Kramer G L, Zukas PK, et al. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse. 1994 ; 18: 294-297
40. Kamali M, Oquendo MA, Mann JJ. Understanding the neurobiology of suicidal behavior. Depress Anxiety. 2001 ; 14: 164-176
41. Linnoila M, Virkkunen M, Scheinin M, et al. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 1983 ; 33: 2609-2614
42. Liu YP, Lin YL, Chuang CH, et al. Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task. J Biomed Sci. 2009 ; 16: 72
43. Luscombe GP, Hopcroft RH, Thomas PC, et al. The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology. 1989 ; 28: 129-134
44. Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: A focus on the serotonergic system. Neuropsychopharmacology. 2001 ; 24: 467-477
45. Markovitz PJ, Wagner SC. Venlafaxine in the treatment of borderline personality disorder. Psychopharmacol Bull. 1995 ; 31: 773-777
46. Millan MJ, Gobert A, Girardon S, Dekeyne A. Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline. Eur J Pharmacol. 1999 ; 364: 147-150
47. Millan MJ, Gobert A, Lejeune F, et al. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-Hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocotical dopaminergic and adrenergic pathways. JPET. 2003 ; 306: 954-964
48. Milstein JA, Dalley JW, Robbins TW. Methylphenidate-induced impulsivity: pharmacological antagonism by beta-adrenoreceptor blockade. J Psychopharmacol. 2010 ; 24: 309-321
49. Navarra R, Graf R, Huang Y, et al. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry. 2008 ; 32: 34-41
50. Nolan KA, D'Angelo D, Hoptman MJ. Self-report and laboratory measures of impulsivity in patients with schizophrenia or schizoaffective disorder and healthy controls. Psychiatry Res. 2011 ; 187: 301-303
51. Paine TA, Tomasiewicz HC, Zhang K, et al. Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley Rats. Biol Psychiatry. 2007 ; 62: 687-693
52. Paterson NE, Ricciardi J, Wetzler C, et al. Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. Neurochem Res. 2011 ; 69: 41-50
53. Pattij T, Vanderschuren LJ. The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci. 2008 ; 29: 192-199
54. Pattij T, Schetters D, Schoffelmeer AN, et al. On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists. Psychopharmacology (Berl). 2012 ; 219: 327-340
55. Perroud N, Baud P, Mouthon D, et al. Impulsivity, aggression and suicidal behaviour in unipolar and bipolar disorders. J Affect Disord. 2011 ; 134: 112-118
56. Purselle DC, Nemeroff CB. Serotonin transporter: A potential substrate in the biology of suicide. Neuropsychopharmacology. 2003 ; 28: 613-619
57. Puumala T, Sirviö J. Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task. Neuroscience. 1998 ; 83: 489-499
58. Reid S, Barbui C. Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants. BMJ. 2010 ; 340: c1468
59. Robbins TW. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology. 2002 ; 163: 362-380
60. Robinson ES. Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks. Psychopharmacology (Berl). 2012 ; 219: 303-312
61. Robinson ES, Eagle DM, Mar AC, et al. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology. 2008a ; 33: 1028-1037
62. Robinson ES, Dalley JW, Theobald DE, et al. Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacology. 2008b ; 33: 2398-2406
63. Rowley HL, Butler SA, Prow MR, et al. Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats. Synapse. 2000 ; 38: 167-176
64. Rutter JJ, Gundlah C, Auerbach SB. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse. 1995 ; 20: 225-233
65. Soubrié P. Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci. 1986 ; 9: 319-364
66. Stahl SM, Grady MM, Moret C, et al. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectrum. 2005 ; 10: 732-747
67. Swanson CJ, Perry KW, Koch-Krueger S, et al. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology. 2006 ; 50: 755-760
68. Thomas DN, Nutt DJ, Holman RB. Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex. J Psychopharmacol. 1998 ; 12: 366-370
69. Tsutsui-Kimura I, Ohmura Y, Izumi T, et al. The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats. Behav Pharmacol. 2009 ; 20: 474-483
70. Walderhaug E, Landrø NI, Magnusson A. A synergic effect between lowered serotonin and novel situations on impulsivity measured by CPT. J Clin Exp Neuropsychol. 2008 ; 30: 204-211
71. Walderhaug E, Lunde H, Nordvik JE, et al. Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal individuals. Psychopharmacology (Berl). 2002 ; 164: 385-391
72. Wilens TE. Mechanism of action of agents used in attention-deficit/ hyperactivity disorder. J Clin Psychiatry. 2006 ; 67: 32-38
73. Winstanley CA. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol. 2011 1301 1321 ; 164 :
74. Winstanley CA, Eagle DM, Robbins TW. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev. 2006 ; 26: 379-395
75. Winstanley CA, Theobald DE, Dalley JW, et al. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology. 2004 ; 176: 376-385
76. Wortley KE, Hughes ZA, Heal DJ, et al. Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by α2-adrenoceptors. Br J Pharmacol. 1999 ; 127: 1860-1866
77. Van Gaalen MM, Koten R, Schoffelmeer AN, et al. Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry. 2006 ; 60: 66-73
78. Yamamoto BK, Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem. 1998 ; 71: 274-280
79. Zapolski TCB, Settles RE, Cyders MA, et al. Borderline personality disorder, bulimia nervosa, antisocial personality disorder, ADHD, substance use: common threads, common treatment needs, and the nature of impulsivity. Indep Pract. 2010 ; 30: 20-23
80. Zhang W, Perry KW, Wong DT, et al. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology. 2000 ; 23: 250-262